Mayo Clinic and Kaiser Permanente recently joined forces to invest $100 million in Medically Home, a technology services company that enables acute-level care in the home – a sign of just how much health systems are looking to push the boundaries of how they take care of patients there. It’s worth noting that Medically Home believes HME providers – with their presence in the community and their logistics expertise – are in many ways at the leading edge of this hospital-at-home movement. Hear why Rami Karjian, co-founder and CEO of Medically Home, believes that HME providers that can rethink their roles will position themselves at the forefront of this latest innovation in health care delivery.
Rami Karjian, co-founder and CEO, Medically Home
The top execs at Apria Healthcare, AdaptHealth, Lincare and Rotech are back for a panel session at this year’s Summit. How has the public health emergency changed how patients see health care and, more specifically, HME? How are they leveraging the increased focus on care in the home to elevate their companies and the industry? Why do they think the industry is primed for technological overlays? What will M&A and consolidation look like in the next 12 to 24 months? Hear them address these topics and more in a one-hour discussion with Q&A.
Clint Geffert, president, VGM & Associates
Dan Starck, CEO, Apria Healthcare
Stephen Griggs, co-CEO, AdaptHealth
Crispin Teufel, CEO, Lincare
Timothy Pigg, president and CEO, Rotech
The COVID-19 pandemic has highlighted the need to expand and strengthen the care patients receive at home. Payers have expanded the use of telehealth, but that’s just a first step. How will home care evolve? Recent events have pushed this topic to the forefront for all of health care. Don’t be left behind as AAHomecare’s Laura Williard closely examines the following questions with our panelists: How has the pandemic changed how payers view home care? How have payers made it more of a priority? How will the pandemic influence how payers cover and pay for home care products and services in the future? How has it accelerated value-based care? What other disruptors do payers see in the health care, including technology?
Laura Williard, vice president, payer relations, AAHomecare
Nathan Ray leads a health care M&A team at West Monroe that works with strategic buyers and private equity sponsors on more than 160 transactions and more than 100 post-close engagements per year. His specialty: emerging technologies and business models, acquisitive provider platforms and analytics. He has been recently quoted on Amazon’s decision to expand Amazon Care, the company’s virtual health service benefit, and its potential move into at-home medical tests. Industry veteran Gary Sheehan, who recently led the sale of a portfolio of HME companies to AdaptHealth, will engage Ray in a conversation on the fast-moving changes in health care’s footprint.
Gary Sheehan, senior vice president, regional operations, AdaptHealth New England
Nathan Ray, director, Healthcare & Life Sciences, West Monroe
Health care companies are looking to strategic, value-based arrangements as a way to get paid for better quality and outcomes, and to control costs. Healthcare attorney Jeanna Palmer Gunville will share emerging trends in this space – what have we seen over the past year and what we can expect to see in the rest of 2021 and beyond? She’ll review the opportunities that new regulatory flexibilities and care delivery innovation have created, outline how to capitalize on new infrastructure in telehealth and other digital health modalities, and discuss what the options are for provider and vendor relationships in the HME industry.
Jeanna Palmer Gunville, shareholder, Polsinelli
A number of HME providers are turning to the public markets to drive growth – Apria Healthcare and Quipt Home Medical (formerly Protech Home Medical) among the most recent. Don Davis will share a financial analysis of public companies in the HME industry, as well as a few public companies in ancillary industries, to give you a new perspective on your company and get you thinking about different business models. Additionally, what is the impact of having an increasing number of HME providers listed on the NASDAQ? Has it made HME a more attractive investment opportunity? How has it affected valuation? Will more HME providers follow suit?
Don Davis, president, Duckridge Advisors
Each year, HME providers participate in this one-of-a-kind survey to see how they stack up against their peers in everything from net revenues to DSO to employee expenses. New this year: salary information, including average compensation for various positions. What do the numbers look like for 2020, a year dominated by the COVID-19 pandemic? The results will be revealed and analyzed during this session.
Mark Higley, vice president of regulatory affairs, VGM Group